Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Post-discontinuation, 19.6 % restarted the original medication, while 35 % adopted another option: alternative medication (27.4 %), healthcare visit for lifestyle modification (13.7 %), and metabolic and bariatric surgery (0.6 %)
CrossRef Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yaewon Yang, Seock-Ah Im, Bhumsuk Keam, KyungHun Lee, TaeYong Kim, Koung Jin Suh, Han Suk Ryu, Hyeong-Gon Moon, SaeWon Han, DoYoun Oh, Wonshik Han, TaeYou Kim, In Ae Park, Dong-Young Noh BMC Cancer.2016;[Epub] CrossRef High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer Ji Soo Park, Hong Jae Chon, Hei-Cheul Jeung, Sang Joon Shin, Sun Young Rha, Joong Bae Ahn, Kang Young Lee, Nam Kyu Kim, Hyun Cheol Chung Journal of Cancer Research and Clinical Oncology.2016
For many patients, this leads to gradual weight reduction as calorie intake decreases
R.ProssnitzE
